U.S. FDA's banner

U.S. FDA

@FDA • 591,702 subscribers

Our posts are FDA Approved! Privacy Policy - https://t.co/LbTJXYRXVP FDA Authentic Accounts - https://t.co/w2LNbzG7M0

Shorts

FDA proposes to exclude semaglutide, tirzepatide, and liraglutide on the 503B bulks list. After careful review, we did not identify sufficient clinical need for outsourcing facilities to compound these drugs from bulk substances. Public comment period now open. Learn more:

FDA proposes to exclude semaglutide, tirzepatide, and liraglutide on the 503B bulks list. After careful review, we did not identify sufficient clinical need for outsourcing facilities to compound these drugs from bulk substances. Public comment period now open. Learn more:

105,392 views

Videos

Anya Rossi

sweetdream.ai

SweetDream.ai•Sponsored•Livecam

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

Exclusive private shows

1.2k viewers online

Private Show

Join now for exclusive access

Free preview available • Premium content

"We have the safest food supply in the world." – Acting Commissioner Deputy Commissioner Kyle Diamantas on CNBC. "Americans should feel confident in eating fresh produce including leafy greens at this point. FDA remains confident that all iceberg lettuce related to the cyclospora outbreak has been effectively removed from the market."

"We have the safest food supply in the world." – Acting Commissioner Deputy Commissioner Kyle Diamantas on CNBC. "Americans should feel confident in eating fresh produce including leafy greens at this point. FDA remains confident that all iceberg lettuce related to the cyclospora outbreak has been effectively removed from the market."

46,110 views • 6 days ago

Today, FDA provided important updates on the risk of myocarditis after receiving an mRNA COVID-19 vaccine, noting the risk is higher in young men.

Today, FDA provided important updates on the risk of myocarditis after receiving an mRNA COVID-19 vaccine, noting the risk is higher in young men.

1,898,803 views • 1 year ago

FDA approved two new drugs for rare diseases this week! Learn more about these approvals and other good news:

FDA approved two new drugs for rare diseases this week! Learn more about these approvals and other good news:

30,360 views • 4 months ago

For patients with severe Leukocyte Adhesion Deficiency Type I (LAD-I), treatment options have been limited. A new gene therapy may offer hope through the FDA’s accelerated approval pathway.

For patients with severe Leukocyte Adhesion Deficiency Type I (LAD-I), treatment options have been limited. A new gene therapy may offer hope through the FDA’s accelerated approval pathway.

10,387 views • 4 months ago

No more content to load